出版物 | サターラ

論文

Publication X

The Role of Model Master Files for Sharing, Acceptance, and Communication with FDA

Guide to development of compound files for PBPK modeling in the Simcyp population-based simulator

Real-world application of PBPK in drug discovery

Physiologically Based Pharmacokinetic modelling of drugs in pregnancy: A mini-review on availability and limitations

A Literature Review of Changes in Phase II Drug-Metabolizing Enzyme and Drug Transporter Expression during Pregnancy

Total and Free Blood and Plasma Concentration Changes in Pregnancy for Medicines Highly Bound to Plasma Proteins: Application of Physiologically Based Pharmacokinetic Modelling to Understand the Impact on Efficacy

A quantitative clinical pharmacology-based framework for model-informed vaccine development

No Recipe for Quantitative Systems Pharmacology Model Validation, but a Balancing Act Between Risk and Cost

Analysis of clinical failure of anti-tau and anti-synuclein antibodies in neurodegeneration using a quantitative systems pharmacology model

Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion

Computational neurosciences and quantitative systems pharmacology: a powerful combination for supporting drug development in neurodegenerative diseases

QSP Designer: Quantitative systems pharmacology modeling with modular biological process map notation and multiple language code generation

Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients with Unresectable Hepatocellular Carcinoma

Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers

Powered by Translations.com GlobalLink OneLink Software